![]() |
|
|
Vol. 289, Issue 2, 632-640, May 1999
Endocrine (X.-L.Z., Y.G., M.D.H.) and
Neuroscience (K.A.S.)
Research Groups, In rat aorta rings (RA) and in gastric circular muscle (CM) and gastric
longitudinal muscle (LM) preparations maintained in vitro,
inducible nitric oxide synthase (iNOS) induction was monitored functionally (1 mM L-arginine-induced relaxation),
biochemically (appearance of iNOS mRNA), and immunohistochemically.
Functional iNOS (L-arginine-mediated relaxation) was
induced in RA and CM tissues (but NOT in the LM preparation) over 2 to
5 h. iNOS induction was detected by immunocytochemistry in RA
smooth muscle elements and in macrophage-like cells in CM. Functional
iNOS induction correlated with iNOS mRNA induction. In the RA and CM,
functional iNOS induction was blocked by both actinomycin D and
cycloheximide; actinomycin D also blocked the appearance of iNOS mRNA
in both tissues. In contrast, cycloheximide blocked CM (but not RA)
iNOS mRNA induction. In CM tissue, functional iNOS induction was not affected by genistein, tyrphostin 47/AG213, or vanadate. But, in the
RA, both genistein and tyrphostin 47/AG213 blocked the appearance of
functional iNOS; neither inhibitor prevented the appearance of RA iNOS
mRNA. Vanadate, in the RA tissue, blocked both the appearance of iNOS
mRNA and the induction of functional iNOS. In RA tissue, but not in the
CM, inhibitors of NF-
B activation blocked the appearance of
both functional iNOS and iNOS mRNA. We conclude that in different
smooth muscle preparations (aorta versus gastric), there can be a
differential induction of iNOS mRNA and "functional" iNOS not only
in different cellular elements but also in terms of different signaling pathways.
0022-3565/99/2892-0632$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
J. Blanchette, P. Pouliot, and M. Olivier Role of protein tyrosine phosphatases in the regulation of interferon-{gamma}-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation J. Leukoc. Biol., March 1, 2007; 81(3): 835 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Forget, D. J. Gregory, L. A. Whitcombe, and M. Olivier Role of Host Protein Tyrosine Phosphatase SHP-1 in Leishmania donovani-Induced Inhibition of Nitric Oxide Production. Infect. Immun., November 1, 2006; 74(11): 6272 - 6279. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Koetzler, M. Saifeddine, Z. Yu, F.S. Schurch, M. D. Hollenberg, and F. H. Y. Green Surfactant as an Airway Smooth Muscle Relaxant Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 609 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Foti, R. Iuliano, E. Chiefari, and A. Brunetti A Nucleoprotein Complex Containing Sp1, C/EBP{beta}, and HMGI-Y Controls Human Insulin Receptor Gene Transcription Mol. Cell. Biol., April 15, 2003; 23(8): 2720 - 2732. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gui, X.-L. Zheng, and M. D. Hollenberg Interleukin-1beta , Src- and non-Src tyrosine kinases, and nitric oxide synthase induction in rat aorta in vitro Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H566 - H576. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Zheng, S. Matsubara, C. Diao, M. D. Hollenberg, and N. C. W. Wong Activation of Apolipoprotein AI Gene Expression by Protein Kinase A and Kinase C through Transcription Factor, Sp1 J. Biol. Chem., October 6, 2000; 275(41): 31747 - 31754. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Zheng, S. Matsubara, C. Diao, M. D. Hollenberg, and N. C. W. Wong Epidermal Growth Factor Induction of Apolipoprotein A-I Is Mediated by the Ras-MAP Kinase Cascade and Sp1 J. Biol. Chem., April 20, 2001; 276(17): 13822 - 13829. [Abstract] [Full Text] [PDF] |
||||